Redmile Group LLC 13D and 13G filings for Celldex Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 5:07 pm Sale |
2021-12-31 | 13G | Celldex Therapeutics, Inc. CLDX |
Redmile Group LLC | 2,165,586 4.600% |
-546,030 (-20.14%) |
Filing |
| 2021-02-16 4:07 pm Purchase |
2020-12-31 | 13G | Celldex Therapeutics, Inc. CLDX |
Redmile Group LLC | 2,711,616 6.900% |
2,711,616 (New Position) |
Filing |